Harbert Fund Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Harbert Fund Advisors's IBB Position: Q4 2024 in Review
Harbert Fund Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 3,500 shares — an estimated $510K sold.
Harbert Fund Advisors first reported a position in IBB in Q2 2024 and held it in 2 quarters. The position peaked at $510K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Harbert Fund Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- Harbert Fund Advisors sold 3,500 iShares Biotechnology ETF shares in Q4 2024, an estimated $510K.
- Harbert Fund Advisors first reported a position in iShares Biotechnology ETF in Q2 2024 and held it in 2 quarters.
- Harbert Fund Advisors's iShares Biotechnology ETF position peaked at $510K in Q3 2024.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Harbert Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.